214 related articles for article (PubMed ID: 28466852)
1. Temporal and tissue-specific requirements for T-lymphocyte IL-6 signalling in obesity-associated inflammation and insulin resistance.
Xu E; Pereira MMA; Karakasilioti I; Theurich S; Al-Maarri M; Rappl G; Waisman A; Wunderlich FT; Brüning JC
Nat Commun; 2017 May; 8():14803. PubMed ID: 28466852
[TBL] [Abstract][Full Text] [Related]
2. Interleukin-6 deficiency facilitates myocardial dysfunction during high fat diet-induced obesity by promoting lipotoxicity and inflammation.
Chen F; Chen D; Zhao X; Yang S; Li Z; Sanchis D; Jin L; Qiang X; Wang K; Xu Y; Zhang Y; Ye J
Biochim Biophys Acta Mol Basis Dis; 2017 Dec; 1863(12):3128-3141. PubMed ID: 28844956
[TBL] [Abstract][Full Text] [Related]
3. IL-7 receptor deletion ameliorates diet-induced obesity and insulin resistance in mice.
Lee M; Song SJ; Choi MS; Yu R; Park T
Diabetologia; 2015 Oct; 58(10):2361-70. PubMed ID: 26152662
[TBL] [Abstract][Full Text] [Related]
4. Interleukin-6 signaling in liver-parenchymal cells suppresses hepatic inflammation and improves systemic insulin action.
Wunderlich FT; Ströhle P; Könner AC; Gruber S; Tovar S; Brönneke HS; Juntti-Berggren L; Li LS; van Rooijen N; Libert C; Berggren PO; Brüning JC
Cell Metab; 2010 Sep; 12(3):237-49. PubMed ID: 20816090
[TBL] [Abstract][Full Text] [Related]
5. Blockade of interleukin 6 signalling ameliorates systemic insulin resistance through upregulation of glucose uptake in skeletal muscle and improves hepatic steatosis in high-fat diet fed mice.
Yamaguchi K; Nishimura T; Ishiba H; Seko Y; Okajima A; Fujii H; Tochiki N; Umemura A; Moriguchi M; Sumida Y; Mitsuyoshi H; Yasui K; Minami M; Okanoue T; Itoh Y
Liver Int; 2015 Feb; 35(2):550-61. PubMed ID: 25066281
[TBL] [Abstract][Full Text] [Related]
6. CTRP3 deficiency reduces liver size and alters IL-6 and TGFβ levels in obese mice.
Wolf RM; Lei X; Yang ZC; Nyandjo M; Tan SY; Wong GW
Am J Physiol Endocrinol Metab; 2016 Mar; 310(5):E332-45. PubMed ID: 26670485
[TBL] [Abstract][Full Text] [Related]
7. Angiotensin-converting enzyme inhibition reverses diet-induced obesity, insulin resistance and inflammation in C57BL/6J mice.
Premaratna SD; Manickam E; Begg DP; Rayment DJ; Hafandi A; Jois M; Cameron-Smith D; Weisinger RS
Int J Obes (Lond); 2012 Feb; 36(2):233-43. PubMed ID: 21556046
[TBL] [Abstract][Full Text] [Related]
8. Placental growth factor (PlGF) is linked to inflammation and metabolic disorders in mice with diet-induced obesity.
Kang M; Jeong J; Lee J; Park S; Sung Y; Choi M; Kwon W; Jang S; Choi KS; Choo YS; Yoon D; Kim MO; Ryoo ZY
Endocr J; 2018 Apr; 65(4):437-447. PubMed ID: 29434073
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of Gastric Inhibitory Polypeptide Receptor Signaling in Adipose Tissue Reduces Insulin Resistance and Hepatic Steatosis in High-Fat Diet-Fed Mice.
Joo E; Harada N; Yamane S; Fukushima T; Taura D; Iwasaki K; Sankoda A; Shibue K; Harada T; Suzuki K; Hamasaki A; Inagaki N
Diabetes; 2017 Apr; 66(4):868-879. PubMed ID: 28096257
[TBL] [Abstract][Full Text] [Related]
10. Blocking high-fat diet-induced obesity, insulin resistance and fatty liver by overexpression of Il-13 gene in mice.
Darkhal P; Gao M; Ma Y; Liu D
Int J Obes (Lond); 2015 Aug; 39(8):1292-9. PubMed ID: 25869601
[TBL] [Abstract][Full Text] [Related]
11. Interleukin 6 receptor is not directly involved in regulation of body weight in diet-induced obesity with and without physical exercise.
Minafra AR; Chadt A; Rafii P; Al-Hasani H; Behnke K; Scheller J
Front Endocrinol (Lausanne); 2022; 13():1028808. PubMed ID: 36387898
[TBL] [Abstract][Full Text] [Related]
12. The dual-specificity phosphatase 2 (DUSP2) does not regulate obesity-associated inflammation or insulin resistance in mice.
Lancaster GI; Kraakman MJ; Kammoun HL; Langley KG; Estevez E; Banerjee A; Grumont RJ; Febbraio MA; Gerondakis S
PLoS One; 2014; 9(11):e111524. PubMed ID: 25375135
[TBL] [Abstract][Full Text] [Related]
13. IL-21 is a major negative regulator of IRF4-dependent lipolysis affecting Tregs in adipose tissue and systemic insulin sensitivity.
Fabrizi M; Marchetti V; Mavilio M; Marino A; Casagrande V; Cavalera M; Moreno-Navarrete JM; Mezza T; Sorice GP; Fiorentino L; Menghini R; Lauro R; Monteleone G; Giaccari A; Fernandez Real JM; Federici M
Diabetes; 2014 Jun; 63(6):2086-96. PubMed ID: 24430438
[TBL] [Abstract][Full Text] [Related]
14. Pu-erh tea extract ameliorates high-fat diet-induced nonalcoholic steatohepatitis and insulin resistance by modulating hepatic IL-6/STAT3 signaling in mice.
Cai X; Fang C; Hayashi S; Hao S; Zhao M; Tsutsui H; Nishiguchi S; Sheng J
J Gastroenterol; 2016 Aug; 51(8):819-29. PubMed ID: 26794005
[TBL] [Abstract][Full Text] [Related]
15. Signaling by IL-6 promotes alternative activation of macrophages to limit endotoxemia and obesity-associated resistance to insulin.
Mauer J; Chaurasia B; Goldau J; Vogt MC; Ruud J; Nguyen KD; Theurich S; Hausen AC; Schmitz J; Brönneke HS; Estevez E; Allen TL; Mesaros A; Partridge L; Febbraio MA; Chawla A; Wunderlich FT; Brüning JC
Nat Immunol; 2014 May; 15(5):423-30. PubMed ID: 24681566
[TBL] [Abstract][Full Text] [Related]
16. IL-37 protects against obesity-induced inflammation and insulin resistance.
Ballak DB; van Diepen JA; Moschen AR; Jansen HJ; Hijmans A; Groenhof GJ; Leenders F; Bufler P; Boekschoten MV; Müller M; Kersten S; Li S; Kim S; Eini H; Lewis EC; Joosten LA; Tilg H; Netea MG; Tack CJ; Dinarello CA; Stienstra R
Nat Commun; 2014 Sep; 5():4711. PubMed ID: 25182023
[TBL] [Abstract][Full Text] [Related]
17. Medium-chain triglyceride ameliorates insulin resistance and inflammation in high fat diet-induced obese mice.
Geng S; Zhu W; Xie C; Li X; Wu J; Liang Z; Xie W; Zhu J; Huang C; Zhu M; Wu R; Zhong C
Eur J Nutr; 2016 Apr; 55(3):931-40. PubMed ID: 25911003
[TBL] [Abstract][Full Text] [Related]
18. Diet-genotype interactions in the early development of obesity and insulin resistance in mice with a genetic deficiency in tumor necrosis factor-alpha.
Bouter B; Geary N; Langhans W; Asarian L
Metabolism; 2010 Jul; 59(7):1065-73. PubMed ID: 20045154
[TBL] [Abstract][Full Text] [Related]
19. PAFR in adipose tissue macrophages is associated with anti-inflammatory phenotype and metabolic homoeostasis.
Filgueiras LR; Koga MM; Quaresma PG; Ishizuka EK; Montes MB; Prada PO; Saad MJ; Jancar S; Rios FJ
Clin Sci (Lond); 2016 Apr; 130(8):601-12. PubMed ID: 26785675
[TBL] [Abstract][Full Text] [Related]
20. Recent advances in the relationship between obesity, inflammation, and insulin resistance.
Bastard JP; Maachi M; Lagathu C; Kim MJ; Caron M; Vidal H; Capeau J; Feve B
Eur Cytokine Netw; 2006 Mar; 17(1):4-12. PubMed ID: 16613757
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
